Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Non-Current Deffered Revenue (2022 - 2026)

Core Laboratories filings provide 5 years of Non-Current Deffered Revenue readings, the most recent being $28.2 million for Q1 2026.

  • On a quarterly basis, Non-Current Deffered Revenue fell 3.53% to $28.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $28.2 million, a 3.53% decrease, with the full-year FY2025 number at $29.4 million, down 5.57% from a year prior.
  • Non-Current Deffered Revenue hit $28.2 million in Q1 2026 for Core Laboratories, down from $29.4 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $31.8 million in Q4 2022 to a low of $28.2 million in Q1 2026.
  • Median Non-Current Deffered Revenue over the past 5 years was $30.4 million (2024), compared with a mean of $30.2 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: rose 8.44% in 2024 and later fell 5.57% in 2025.
  • Core Laboratories' Non-Current Deffered Revenue stood at $31.8 million in 2022, then fell by 3.99% to $30.5 million in 2023, then increased by 1.87% to $31.1 million in 2024, then dropped by 5.57% to $29.4 million in 2025, then dropped by 4.14% to $28.2 million in 2026.
  • The last three reported values for Non-Current Deffered Revenue were $28.2 million (Q1 2026), $29.4 million (Q4 2025), and $31.1 million (Q3 2025) per Business Quant data.